Skip to main content
. 2019 Sep 29;12:1178638819879444. doi: 10.1177/1178638819879444

Table 1.

Demographic and outcome characteristics of the MONT pilot cohort.

No. (%) Supplement usea
χ2 df P value
No (n = 38) Yes (n = 89)
Age group
 ⩽24 27 (21.2) 12 (44.4) 15 (55.6) 3.537 3 .316
 25–29 40 (31.5) 10 (25.0) 30 (75.0)
 30–34 39 (30.7) 10 (25.6) 29 (74.4)
 ⩾35 21 (16.5) 6 (28.6) 15 (71.4)
BMI
 Lean (<25 kg/m2) 73 (57.5) 18 (24.7) 55 (75.3) 1.337 1 .248
 Overweight (⩾25 kg/m2) 50 (39.4) 18 (36.0) 32 (64.0)
Cultural and linguistic diversity (CALD)
 No 91 (71.7) 23 (25.3) 68 (74.7) 2.570 1 .109
 Yes 36 (28.3) 15 (41.7) 21 (58.3)
Income
 <50k 40 (31.5) 15 (37.5) 25 (62.5) 2.638 3 .451
 50–70k 23 (18.1) 8 (34.8) 15 (65.2)
 70–120k 34 (26.8) 8 (23.5) 26 (76.5)
 >120k 30 (23.6) 7 (23.3) 23 (76.7)
Education
 Did not attend/finish high school 23 (18.5) 11 (47.8) 12 (52.2) 7.974 3 .047b
 Finished high school 34 (26.8) 13 (38.2) 21 (61.8)
 TAFE trade or apprenticeship 22 (17.3) 4 (18.2) 18 (81.8)
 University degree 48 (37.8) 10 (20.8) 38 (79.2)
Parity
 Nulliparous 73 (57.5) 15 (20.5) 58 (79.5) 6.181 1 .013b
 Multiparous 54 (42.5) 23 (42.6) 31 (57.4)
Smoker
 No 118 (92.9) 32 (27.1) 86 (72.9) 6.040 1 .014b
 Yes 9 (7.1) 6 (75.0) 2 (25.0)
Hypertensive disorders
 No 115 (86.6) 34 (29.6) 81 (70.4) 0.000 1 .000
 Yes 12 (9.4) 2 (33.3) 8 (66.7)
Gestational diabetes
 No 110 (86.6) 31 (28.2) 79 (71.8) 0.647 1 .276
 Yes 17 (13.4) 7 (41.2) 10 (58.8)
Preterm birth (idiopathic)
 No 105 (82.7) 31 (29.5) 74 (70.5) 0.728 1 .394
 Yes 16 (12.6) 7 (43.8) 9 (56.2)
Birth >41 weeks
 No 114 (89.8) 36 (31.6) 78 (68.4) 0.789 1 .374
 Yes 13 (10.2) 2 (15.4) 11 (84.6)
Induction of labour (excluding no labour)
 No 54 (42.5) 17 (31.5) 37 (68.5) 0.115 1 .734
 Yes 42 (33.1) 11 (26.2) 31 (73.8)
Low birthweight baby (excluding multiple births)
 No 101 (79.5) 32 (31.7) 69 (68.3) 0.000 1 1.000
 Yes 19 (15.0) 6 (31.6) 13 (68.4)

Abbreviations: BMI, body mass index; CALD, cultural and linguistic diversity; MONT, Maternal Outcomes and Nutrition Tool.

a

Includes multiple and individual micronutrient supplements.

b

Statistically significant.